Bradykinin antagonists: present progress and future prospects.

@article{Stewart1999BradykininAP,
  title={Bradykinin antagonists: present progress and future prospects.},
  author={John M Stewart and Lajos Gera and Eunice J. York and Daniel K. C. Chan and Paul A. Bunn},
  journal={Immunopharmacology},
  year={1999},
  volume={43 2-3},
  pages={155-61}
}
Bradykinin (BK) antagonist peptides have been powerful tools for delineating roles of kinins in both normal and pathological physiology and offer promise of drug development for a variety of inflammatory conditions and cancers. At the present time, potent peptide antagonists are available that are either specific for BK B1 or B2 receptors, or are effective on both receptor classes. Non-peptide BK B2 antagonists are now being announced and are under investigation in several companies. The best… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

Similar Papers

Loading similar papers…